A Multiinstitutional Feasibility Study of Trimodality Therapy for Resectable Malignant Mesothelioma
暂无分享,去创建一个
T. Yamanaka | M. Okada | T. Nakano | F. Tanaka | K. Fukuoka | T. Tsujimura | S. Hasegawa | K. Inai | T. Soejima | N. Kamikonya
[1] M. Okada,et al. Current Status of Multi-modality Treatment for Malignant Pleural Mesothelioma in Japan , 2008 .
[2] Laurence Court,et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. , 2006, International journal of radiation oncology, biology, physics.
[3] K. Rosenzweig,et al. Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] R. Flores. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience. , 2005, Lung cancer.
[5] R. Stahel,et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] V. Rusch. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Claude Denham,et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. V. van Klaveren,et al. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma , 2002, British Journal of Cancer.
[9] K. Rosenzweig,et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.
[10] M. Ghielmini,et al. The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] A. Musk,et al. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] W. Richards,et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.
[13] V. Rusch,et al. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. , 1991, The Journal of thoracic and cardiovascular surgery.
[14] H. Bloom,et al. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. , 1984, Thorax.
[15] Ramon Silva Martins,et al. Malignant pleural mesothelioma. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.